Published in J Neural Transm (Vienna) on December 01, 2009
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism. Transl Psychiatry (2011) 0.93
A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder. BMC Syst Biol (2010) 0.83
Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling. Pharmacogenomics J (2011) 0.81
Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene. Transl Psychiatry (2015) 0.80
Novel integrative genomic tool for interrogating lithium response in bipolar disorder. Transl Psychiatry (2015) 0.79
Genomics of Lithium Action and Response. Neurotherapeutics (2017) 0.79
Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia. Dis Markers (2013) 0.78
Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines. Pharmacogenomics J (2016) 0.77
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder. Hum Genomics Proteomics (2010) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
The biology of VEGF and its receptors. Nat Med (2003) 32.13
A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A (1996) 11.37
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem (2001) 6.85
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A (2002) 5.09
Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet (2008) 5.08
Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet (1998) 3.89
BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol (2000) 3.77
Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol (2002) 3.49
Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry (2004) 3.23
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays (2004) 2.83
A common mechanism of action for three mood-stabilizing drugs. Nature (2002) 2.58
Enhancement of hippocampal neurogenesis by lithium. J Neurochem (2000) 2.28
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A (2007) 2.22
The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem (1999) 2.20
Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci (2004) 2.17
The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem (1999) 2.04
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry (2004) 1.95
Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci (2003) 1.95
Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol (2004) 1.89
The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry (2007) 1.88
Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain (2007) 1.83
Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem (1999) 1.77
Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A (1998) 1.75
Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci (2008) 1.58
Interaction of reelin signaling and Lis1 in brain development. Nat Genet (2003) 1.56
Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci (2007) 1.47
Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet (2003) 1.46
Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proc Natl Acad Sci U S A (2008) 1.46
Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci (2004) 1.44
Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res (2004) 1.41
Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol (2005) 1.32
Purification and characterization of bovine brain platelet-activating factor acetylhydrolase. J Biol Chem (1993) 1.30
The carboxy terminal C-tail of BNip3 is crucial in induction of mitochondrial permeability transition in isolated mitochondria. Arch Biochem Biophys (2002) 1.26
The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol (2005) 1.25
The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. J Neurosci (2005) 1.10
Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology (2002) 1.10
Reduced inositol content in lymphocyte-derived cell lines from bipolar patients. Bipolar Disord (2002) 1.09
Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood (2001) 1.07
Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet (2006) 1.07
Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol Psychiatry (2008) 1.05
Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells. Neuroscience (2007) 1.04
VEGF serum levels in depressed patients during SSRI antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.02
Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative? PLoS One (2008) 1.02
Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.00
Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells. Cell Death Differ (2006) 1.00
Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience (2006) 0.99
Microarray analysis of rat brain gene expression after chronic administration of sodium valproate. Brain Res Bull (2005) 0.99
Bcl-2 family gene products in cerebral ischemia and traumatic brain injury. J Neurotrauma (2000) 0.99
Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol (2008) 0.94
Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation. J Neurochem (2002) 0.93
Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder. Biol Psychiatry (2007) 0.93
Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol (2003) 0.91
Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes. Stroke (2008) 0.91
Up-regulation of ADM and SEPX1 in the lymphoblastoid cells of patients in monozygotic twins discordant for schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2008) 0.91
High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry (1997) 0.91
Altered gene expression in mice treated with the mood stabilizer sodium valproate. Int J Neuropsychopharmacol (2005) 0.87
Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression. Ann N Y Acad Sci (2003) 0.86
Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos. Brain Res Mol Brain Res (1999) 0.85
Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo. Int J Urol (2007) 0.84
Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder. Neuropsychopharmacology (2004) 0.83
Astroglia growth retardation and increased microglia proliferation by lithium and ornithine decarboxylase inhibitor in rat cerebellar cultures: Cytotoxicity by combined lithium and polyamine inhibition. J Neurosci Res (2007) 0.83
Lithium prevents stress-induced reduction of vascular endothelium growth factor levels. Neurosci Lett (2007) 0.82
Pafah1b2 mutations suppress the development of hydrocephalus in compound Pafah1b1; Reln and Pafah1b1; Dab1 mutant mice. Neurosci Lett (2008) 0.82
Modulation of angiogenesis-related protein synthesis by valproic acid. Biochem Biophys Res Commun (2004) 0.80
Mood stabilizing drugs expand the neural stem cell pool in the adult brain through activation of notch signaling. Stem Cells (2008) 0.78
Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells. Eur J Pharmacol (2004) 0.76
Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 7.02
Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –. Circ J (2012) 3.70
Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell (2009) 3.45
Nutritional biochemistry: A new redox-cofactor vitamin for mammals. Nature (2003) 2.97
Epidemiology of esophageal cancer in Japan and China. J Epidemiol (2013) 2.66
Infant calming responses during maternal carrying in humans and mice. Curr Biol (2013) 2.35
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet (2004) 2.31
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol (2011) 1.89
Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci (2012) 1.80
Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet (2006) 1.78
Diabetes in Japan: a review of disease burden and approaches to treatment. Diabetes Metab Res Rev (2009) 1.76
Serum cholesterol, uric acid and cholinesterase in victims of the Tokyo subway sarin poisoning: a relation with post-traumatic stress disorder. Neurosci Res (2002) 1.73
Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res (2011) 1.61
Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis (2009) 1.52
DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci (2005) 1.49
Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: a 2-year longitudinal study. Pacing Clin Electrophysiol (2010) 1.48
Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet (2003) 1.46
Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res (2007) 1.30
Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology (2008) 1.29
A group-theoretical notation for disease states: an example using the psychiatric rating scale. Theor Biol Med Model (2012) 1.29
RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett (2003) 1.26
Detection of chromosomal structural alterations in single cells by SNP arrays: a systematic survey of amplification bias and optimized workflow. PLoS One (2007) 1.25
Genetic variation of melatonin productivity in laboratory mice under domestication. Proc Natl Acad Sci U S A (2010) 1.24
Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol Psychiatry (2007) 1.22
A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol Psychiatry (2005) 1.20
Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiatry Res (2010) 1.14
The role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development. J Biol Chem (2007) 1.14
Comprehensive gene expression analysis in bipolar disorder. Can J Psychiatry (2007) 1.13
Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 1.11
A polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia. Biol Psychiatry (2005) 1.11
DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet (2013) 1.08
Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci (2004) 1.08
Human brain structural change related to acute single exposure to sarin. Ann Neurol (2007) 1.07
Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet (2006) 1.07
Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist (2006) 1.05
Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res (2002) 1.05
Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J Hum Genet (2012) 1.04
Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. J Hum Genet (2004) 1.04
Incidence and predictors of activation syndrome induced by antidepressants. Depress Anxiety (2008) 1.03
Genome-wide association study of schizophrenia in Japanese population. PLoS One (2011) 1.02
Comprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell lines. Epigenetics (2011) 1.02
Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci Res (2005) 1.01
Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry (2005) 1.01
Epigenetics in mood disorders. Environ Health Prev Med (2007) 1.00
Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies. RNA Biol (2009) 0.99
Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci Res (2004) 0.99
Hypofrontality and microvascular dysregulation in remitted late-onset depression assessed by functional near-infrared spectroscopy. Neuroimage (2005) 0.98
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Dumbbell-shaped osteochondroma of the fifth rib causing spinal cord compression. J Orthop Sci (2009) 0.98
Mitochondrial DNA 3644T-->C mutation associated with bipolar disorder. Genomics (2004) 0.98
DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients. Neurosci Res (2013) 0.97
XBP1 induces WFS1 through an endoplasmic reticulum stress response element-like motif in SH-SY5Y cells. J Neurochem (2006) 0.97
Estimating RNA editing efficiency of five editing sites in the serotonin 2C receptor by pyrosequencing. RNA (2005) 0.96
ERK-FosB signaling in dorsal MPOA neurons plays a major role in the initiation of parental behavior in mice. Mol Cell Neurosci (2007) 0.96
A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biol Psychiatry (2012) 0.96
The association between oxytocin receptor gene (OXTR) polymorphisms and affective temperaments, as measured by TEMPS-A. J Affect Disord (2010) 0.95